JESSICA GENETTI: Open Payments
NPI 1932968617 · ELIZABETHTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,901 in 97 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $660 · 2025 $1,901
Food & beverage: $1,901
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $259 |
| Novo Nordisk Inc | 11 | $205 |
| PFIZER INC. | 14 | $180 |
| ABBVIE INC. | 8 | $178 |
| Lilly USA, LLC | 7 | $134 |
| Mannkind Corporation | 4 | $100 |
| Otsuka America Pharmaceutical, Inc. | 5 | $91 |
| Astellas Pharma US Inc | 3 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
Products named: AIRSUPRA, REXULTI, QULIPTA, Ozempic, MOUNJARO, ELIQUIS, AFREZZA, Veozah.
Industry payments across PA — which companies pay providers there.
